Decibel Therapeutics

YTD

ALL

Why Robinhood?

You can watch DBTX and buy or sell other stocks, ETFs, and their options commission-free!

About DBTX

Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss.

CEO

Laurence E. Reid, PhD

CEOLaurence E. Reid, PhD

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2015

Founded2015

Employees

—

Employees—

DBTX Key Statistics

Market cap

123.37M

Market cap123.37M

Price-Earnings ratio

-1.94

Price-Earnings ratio-1.94

Dividend yield

—

Dividend yield—

Average volume

267.14K

Average volume267.14K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$5.40

52 Week high$5.40

52 Week low

$1.61

52 Week low$1.61

People also own

Based on the portfolios of people who own DBTX. This list is generated using Robinhood data, and it’s not a recommendation.